Skip to content
  • Home
  • Visit our other Journals
    • VJHemOnc
    • VJOncology
    • VJNeurology
    • VJDementia
    • VJHemOnc-E
  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjhemonc logo
VJRegenMed
Logo
  • Specialties
    Hematology
    Oncology
    Musculoskeletal Disorder
    Rare Disease
    Metabolic Disorder
    Cardiovascular Disease
    Ophthalmology
    Neurology
    Infectious Disease
    View all Specialties
  • Technologies
    Cell Therapy
    MSC
    iPSC
    Gene Therapy
    Genome Editing
    Extracellular Vesicles
    CAR-T Therapy
    TCR Therapy
    Tissue-Engineering & Biomaterials
    View all Technologies
  • Topics
    Treatment
    Immuno-Oncology
    Trial Updates
    Perspectives
    Manufacturing
    COVID-19
    View all Topics
  • Conferences
    ASH 2022
    TCT 2022
    Meeting on the Med 2022
    ICLE 2022
    Advanced Therapies Week 2022
    TERMIS 2021
    ESGCT 2021
    Meeting on the Mesa 2021
    Advanced Therapies 2021
    View all Conferences
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

advanced therapies

Updates in cell and gene therapy approvals 1:27
Updates in cell and gene therapy approvals
Bruce Levine • 27 Jan 2022
OCELLOS: A novel advanced therapy orchestration platform 5:12
OCELLOS: A novel advanced therapy orchestration platform
Arturo Araya • 27 Jan 2022
How cell orchestration systems can assist advanced therapy developers 3:54
How cell orchestration systems can assist advanced therapy developers
Arturo Araya • 27 Jan 2022
Trends and innovations within the advanced therapy sector 1:12
Trends and innovations within the advanced therapy sector
Bruce Levine • 27 Jan 2022
Patient-centric innovations in the supply chain 2:00
Patient-centric innovations in the supply chain
Julia Tarasenko • 26 Jan 2022
The effects of COVID-19 on the advanced therapy supply chain 1:16
The effects of COVID-19 on the advanced therapy supply chain
Julia Tarasenko • 26 Jan 2022
The importance of collaboration in cell and gene therapy development 2:27
The importance of collaboration in cell and gene therapy development
Delara Motlagh • 27 Jan 2022
Addressing issues in patients accessing advanced therapies 3:32
Addressing issues in patients accessing advanced therapies
Jason Foster • 27 Jan 2022
Improving the scalability of advanced therapies 2:27
Improving the scalability of advanced therapies
Delara Motlagh • 27 Jan 2022
Differences in supply chains in the CGT industry 1:02
Differences in supply chains in the CGT industry
Julia Tarasenko • 26 Jan 2022
The logistics of manufacturing allogeneic therapies on a large scale 1:02
The logistics of manufacturing allogeneic therapies on a large scale
Julia Tarasenko • 26 Jan 2022
Improving cell therapy manufacturing capabilities 1:11
Improving cell therapy manufacturing capabilities
Lavakumar Karyampudi • 27 Jan 2022
Novel supply chain changes in the advanced therapies space 1:41
Novel supply chain changes in the advanced therapies space
Julia Tarasenko • 26 Jan 2022
Addressing supply chain issues in clinical trials 1:22
Addressing supply chain issues in clinical trials
Arturo Araya • 27 Jan 2022
Digitization in the CGT sector 2:40
Digitization in the CGT sector
Arturo Araya • 27 Jan 2022
Supporting apheresis and manufacturing processes in the CGT space 1:52
Supporting apheresis and manufacturing processes in the CGT space
Delara Motlagh • 27 Jan 2022
  • 1
  • 2
  • 3
  • Next
Journal Pages
  • Specialties
  • Technologies
  • Topics
  • Conferences
Newsletter

Receive the latest news and videos from VJRegenMed via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJRegenMed logo
The content of VJRegenMed is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy